The Filing Desk

EyePoint vs Scilex

EyePoint EYPT · Scilex SCLX · Pharmaceuticals

EyePoint reported revenue of $31 million in fiscal 2025, about the same as Scilex's $30 million in fiscal 2025. EyePoint's revenue fell 27.5% in its latest year, and Scilex's fell 46.5%. EyePoint had an operating margin of -776.0%, against -1143.7% at Scilex. Free cash flow was −$243 million at EyePoint and $4 million at Scilex.

Side by side

EyePointScilex
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$31M$30M
Revenue growth−27.5%−46.5%
Revenue growth a year, last 5 years−1.8%5.1%
Gross margin——
Operating margin−776.0%−1,143.7%
Net margin−739.4%−1,236.4%
Free cash flow−$243M$4M
Free cash flow margin−775.8%12.2%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count30.1%108,662.9%
Last close$0.26$0.65
P/E at the last close——
Insider trades, last 12 monthsbought $71,983, sold $0sold $12.8 million
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
EyePointScilex
Operating margin
Percent of revenue
EyePointScilex
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
EyePointScilex

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the EyePoint and Scilex pages.